Comparison of the effect of fenugreek (Moota) with metformin tablets in improving clinical symptoms and metabolic status of patients with polycystic ovary syndrome (PCOS)

Comparison of the effect of fenugreek tablets (Moota) with metformin tablets in improving the clinical symptoms and metabolic status of patients with polycystic ovary syndrome (PCOS) referred to the clinics of the University of Medical Sciences

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220130053874N1

Enrollment

110

Registered

2022-10-19

Start date

2021-01-04

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: Patients receiving fenugreek medicine. Intervention 2: Control group: Patients receiving Metformin medicine.

Eligibility

Sex/Gender

Female

Age

16 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Female infertility (ovarian factor) 2. Having two of the three criteria of polycystic ovary syndrome: oligomenorrhea or amenorrhea, clinical or biochemical symptoms of hyperandrogenism, polycystic ovaries in ultrasonographic view. 4. Fasting blood sugar (FBS) less than 200 mg / dL 5. Normal liver and kidney function (serum creatinine less than 1.4 mg / dL)

Exclusion criteria

Exclusion criteria: History of medical conditions such as diffuse blood infection, renal failure, congestive heart failure, disorders of chemical characteristics of the kidney, gastrointestinal problems. Type 1 diabetes Adrenal disorders Hypothyroidism Use of other blood sugar medications

Design outcomes

Primary

Measure	Time frame
Improve clinical symptoms. Timepoint: At the beginning of the intervention. Method of measurement: By checklist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahla Mir Galoo-Bayat

Iran University of Medical Sciences

mitrakazerooni.md@gmail.com+98 21 8163 3102

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026